rss

All Presentations

  • Marc Katz, DPM, demonstrates the use of laser treatment for onychomycosis with the CoolTouch CoolBreeze (1320 nm) laser. According to Dr. Katz, the 1320 nm laser is currently undergoing clinical studies to determine the device's efficacy in treating onychomycosis. The CoolTouch CoolBreeze (1320 nm) laser is currently approved for general dermatology use, according to Dr. Katz.

    At the current time, no laser has a specific FDA approved indication for onychomycosis.

    Dr. Katz is board-certified by the American Board of Podiatric Surgery and the American Board of Podiatric Orthopedics and Primary Podiatric Medicine. He is a Fellow of the American Professional Wound Care Association and is in private practice in Tampa, Florida (www.thetampapodiatrist.com or www.vibranttampatoenails.com ).

  • Scott Hirsh, DPM, demonstrates and discusses the use of Gebauer's Ethyl Chloride®, a FDA-approved topical anesthetic skin refrigerant. Ethyl Chloride is intended to control the pain associated with injection and minor surgical procedures.

     

    Dr. Hirsh is in private practice in Cleveland. He is a consultant for Gebauer.

  • Pat Oatman, the 3M Global Marketing Manager for Compression Therapy Systems, discusses the use of compression therapy for venous leg ulcers. She notes that the 3M compression therapy products, including 3M™ Coban™ 2 Layer Compression Therapy, offer intelligent compression dynamics and a thin profile to help facilitate effective compression and patient comfort.

  • Patrick DeHeer, DPM, FACFAS, shares intraoperative pearls with a video on performing a Baxter's nerve release and plantar fasciectomy.

     

    Dr. DeHeer is a Fellow of the American College of Foot and Ankle Surgeons, and is a Diplomate of the American Board of Podiatric Surgery. He is also a team podiatrist for the Indiana Pacers and the Indiana Fever. Dr. DeHeer is in private practice with various offices in Indianapolis.

  • Nicholas A. Giovinco, DPM, Julia Bernardini, DPM, and David G. Armstrong, DPM, MD, PhD, discuss the use of doxycycline as a potential agent for "wound chemotherapy."

    Dr. Giovinco recently graduated from the New York College of Podiatric Medicine. He is a first-year resident at the Dekalb Medical Center in Atlanta and is the curator of www.DrGlass.org. Dr. Bernardini recently graduated from the New York College of Podiatric Medicine and is a first-year resident at the Metropolitan Hospital in New York City. Dr. Armstrong is a Professor of Surgery at the University of Arizona College of Medicine and is the Director of the Southern Arizona Limb Salvage Alliance (SALSA). He is the Founder of CLEAR at the Rosalind Franklin University of Medicine and Science in Chicago.

    References
    1. Scimeca CL, Bharara M, Fisher TK, Giovinco N, Armstrong DG. Novel use of doxycycline in continuous-instillation negative pressure wound therapy as ‘wound chemotherapy.’ Foot Ankle Spec. Jun 8.
    2. Hanemaaijer R, Visser H, Koolwijk P, et al. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res. 1998;12(2):114-118.
    3. De Paiva CS, Corrales RM, Villarreal AL, et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res. 2006;83(3):526-535.
    4. Winzen R, Kracht M, Ritter B, et al. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 1999;18(18):4969-4980.
    5. Hoyt JC, Ballering J, Numanami H, Hayden JM, Robbins RA. Doxycycline modulates nitric oxide production in murine lung epithelial cells. J Immunol. 2006;176(1):567-572.
    6. Abdul-Hussien H, Hanemaaijer R, Verheijen JH, van Bockel JH, Geelkerken RH, Lindeman JH. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content. J Vasc Surg. 2009;49(3):741-749.
    7. Hanemaaijer R, Sorsa T, Konttinen YT, et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem. 1997;272(50):31504-31509.

  • Eric J. Lullove, DPM, PA, shares his insights on the 3M™ Tegaderm™ Matrix Dressing with PHI™ Technology. The Tegaderm™ dressing offers a unique, affordable wound care solution designed to promote the natural moisture balance needed for chronic wound healing. It helps jump-start stalled wounds — including diabetic ulcers, pressure ulcers (stages II-IV) and venous stasis ulcers — and enables them to progress through the normal healing cascade.

     

    Dr. Lullove is in private practice in Boca Raton, Fla. He is the Wound Management Director and Physician Consultant for Home Health Associates in Lake Worth, Fla.

  • Nicholas A. Giovinco, DPM, Julia Bernardini, DPM, Timothy K. Fisher, DPM, and David G. Armstrong, DPM, MD, PhD, present the application of "Chemovac" dressings that combine chemotherapeutic dressings with negative pressure wound therapy. Dr. Giovinco recently graduated from the New York College of Podiatric Medicine. He is a first-year resident at the Dekalb Medical Center in Atlanta and is the curator of www.DrGlass.org. Dr. Bernardini recently graduated from the New York College of Podiatric Medicine and is a first-year resident at the Metropolitan Hospital in New York City. Dr. Fisher is a Limb Salvage Fellow with the Southern Arizona Limb Salvage Alliance (SALSA). Dr. Armstrong is a Professor of Surgery at the University of Arizona College of Medicine and is the Director of SALSA. He is the Founder of CLEAR at the Rosalind Franklin University of Medicine and Science in Chicago.

  • Valerie L. Schade, DPM, AACFAS, and Thomas S. Roukis, DPM, PhD, FACFAS, review the technique for creating polymethylmethacrylate antibiotic-loaded bone cement beads and/or spacers for use in podiatric surgery.

    Dr. Schade is a Fellow with the Limb Preservation Service at the Madigan Army Medical Center in Tacoma, Washington.  She is an Associate of the American College of Foot and Ankle Surgeons.

    Dr. Roukis is a member of the Attending Staff with the Department of Orthopaedics, Podiatry and Sports Medicine at the Gundersen Lutheran Medical Center in La Crosse, Wisconsin. He is a Fellow and a member of the Board of Directors for the American College of Foot and Ankle Surgeons.

  • Removal Of Ingrown Toenail With Phenol And Alcohol Procedure

  • 2nd PIPJ Arthrodesis With Smart Toe Implant From MMI